ISSN 2639-9431
Vol. 4, Issue 1, 2021January 17, 2021 EDT
Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro
Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro
Articles in Vol. 4, Issue 1, 2021
Vol. 4, Issue 1, 2021
- Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitroGuankui WangHanmant GaikwadMary McCarthyMercedes Gonzalez-JuarreroYue LiMichael ArmstrongNichole ReisdorphThomas MorrisonDmitri Simberg
- Rethinking Our COVID-19 StrategySamuel Brauer
- Zebrafish (Danio rerio) as an ecotoxicological model for Nanomaterial induced toxicity profilingSuresh K VermaAditya NandiAdrija SinhaParitosh PatelEalisha JhaSwabhiman MohantyPritam Kumar PandaRajeev AhujaYogendra Kumar MishraMrutyunjay Suar
Wang, Guankui, Hanmant Gaikwad, Mary McCarthy, Mercedes Gonzalez-Juarrero, Yue Li, Michael Armstrong, Nichole Reisdorph, Thomas Morrison, and Dmitri Simberg. 2021. “Lipid Nanoparticle Formulation of Niclosamide (Nano NCM) Effectively Inhibits SARS-CoV-2 Replication in Vitro.” Precision Nanomedicine 4 (1): 724–37. https://doi.org/10.33218/001c.18813.
